Oneness Biotech Co Ltd (4743) — Cash Flow Reinvestment Rate

Latest as of September 2025: 82.76x

Oneness Biotech Co Ltd (4743) has a Cash Flow Reinvestment Rate of 82.76x as of September 2025, reinvesting NT$1.19 Billion (capex NT$5.92 Million plus investments NT$-1.18 Billion) from operating cash flow of NT$14.32 Million. Check 4743 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

82.76x
(Capex + Investments) / Operating CF

Total Reinvested

NT$1.19 Billion
Capex + Investments

Operating Cash Flow

NT$14.32 Million
TWD

Capital Expenditures

NT$5.92 Million
TWD

Oneness Biotech Co Ltd Cash Flow Reinvestment Rate (2010–2020)

Historical reinvestment intensity for Oneness Biotech Co Ltd across 3 annual periods. Explore long-term investment intensity of Oneness Biotech Co Ltd to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Oneness Biotech Co Ltd (2010–2020)

Year-by-year capital reinvestment analysis for Oneness Biotech Co Ltd. For live market cap and broader valuation context, see Oneness Biotech Co Ltd stock valuation.

Year Reinvestment Rate Total Reinvested (TWD) Operating CF Capex YoY Change
2020 36.09x NT$5.71 Billion NT$158.14 Million NT$153.27 Million ▲ +9275.2%
2012 0.39x NT$9.30 Million NT$24.15 Million NT$9.30 Million ▲ +286.2%
2010 0.10x NT$15.28 Million NT$153.25 Million NT$15.28 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow